-
Je něco špatně v tomto záznamu ?
Heterogeneity in the systems of pediatric diabetes care across the European Union
O. Cinek, Z. Sumník, C. de Beaufort, I. Rurik, A. Vazeou, L. Madácsy, NL. Papo, T. Danne, . ,
Jazyk angličtina Země Dánsko
Typ dokumentu hodnotící studie, časopisecké články, multicentrická studie
- MeSH
- diabetes mellitus epidemiologie mortalita terapie MeSH
- dítě MeSH
- endokrinologie metody organizace a řízení normy MeSH
- Evropská unie organizace a řízení statistika a číselné údaje MeSH
- internacionalita MeSH
- kvalita zdravotní péče MeSH
- lidé MeSH
- mladiství MeSH
- pediatrie metody organizace a řízení normy MeSH
- poskytování zdravotní péče * metody organizace a řízení normy MeSH
- průzkumy a dotazníky MeSH
- referenční standardy MeSH
- studium lékařství metody organizace a řízení MeSH
- zdravotnický personál normy statistika a číselné údaje MeSH
- zeměpis MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- mladiství MeSH
- Publikační typ
- časopisecké články MeSH
- hodnotící studie MeSH
- multicentrická studie MeSH
BACKGROUND: It is known that the systems of pediatric diabetes care differ across the member states of the European Union (EU). The aim of this project was to characterize some of the main differences among the national systems. METHODS: Data were collected using two questionnaires. The first one was distributed among leading centers of pediatric diabetes (one per country) with the aim of establishing an overview of the systems, national policies, quality control (QC) and financing of pediatric diabetes care. Responses were received from all 27 EU countries. The second questionnaire was widely disseminated among all 354 International Society for Pediatric and Adolescent Diabetes members with a domicile in an EU country; it included questions related to individual pediatric diabetes centers. A total of 108 datasets were collected and processed from healthcare professionals who were treating more than 29 000 children and adolescents with diabetes. Data on the reimbursement policies were verified by representatives of the pharmaceutical and medical device companies. RESULTS: The collected data reflect the situation in 2009. There was a notable heterogeneity among the systems for provision of pediatric diabetes care across the EU. Only 20/27 EU countries had a pediatric diabetes register. Nineteen countries had officially recognized centers for pediatric diabetes, but only nine of them had defined criteria for becoming such a center. A system for QC of pediatric diabetes at the national level was reported in 7/26 countries. Reimbursement for treatment varied significantly across the EU, potentially causing inequalities in access to modern technologies. CONCLUSIONS: The collected data help develop strategies toward improving equity and access to modern pediatric diabetes care across Europe.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13012380
- 003
- CZ-PrNML
- 005
- 20130408112157.0
- 007
- ta
- 008
- 130404s2012 dk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/j.1399-5448.2012.00907.x $2 doi
- 035 __
- $a (PubMed)22931219
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a dk
- 100 1_
- $a Cinek, Ondrej $u University Hospital Motol, Prague, Czech Republic; Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. Ondrej.Cinek@Lfmotol.cuni.cz
- 245 10
- $a Heterogeneity in the systems of pediatric diabetes care across the European Union / $c O. Cinek, Z. Sumník, C. de Beaufort, I. Rurik, A. Vazeou, L. Madácsy, NL. Papo, T. Danne, . ,
- 520 9_
- $a BACKGROUND: It is known that the systems of pediatric diabetes care differ across the member states of the European Union (EU). The aim of this project was to characterize some of the main differences among the national systems. METHODS: Data were collected using two questionnaires. The first one was distributed among leading centers of pediatric diabetes (one per country) with the aim of establishing an overview of the systems, national policies, quality control (QC) and financing of pediatric diabetes care. Responses were received from all 27 EU countries. The second questionnaire was widely disseminated among all 354 International Society for Pediatric and Adolescent Diabetes members with a domicile in an EU country; it included questions related to individual pediatric diabetes centers. A total of 108 datasets were collected and processed from healthcare professionals who were treating more than 29 000 children and adolescents with diabetes. Data on the reimbursement policies were verified by representatives of the pharmaceutical and medical device companies. RESULTS: The collected data reflect the situation in 2009. There was a notable heterogeneity among the systems for provision of pediatric diabetes care across the EU. Only 20/27 EU countries had a pediatric diabetes register. Nineteen countries had officially recognized centers for pediatric diabetes, but only nine of them had defined criteria for becoming such a center. A system for QC of pediatric diabetes at the national level was reported in 7/26 countries. Reimbursement for treatment varied significantly across the EU, potentially causing inequalities in access to modern technologies. CONCLUSIONS: The collected data help develop strategies toward improving equity and access to modern pediatric diabetes care across Europe.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dítě $7 D002648
- 650 12
- $a poskytování zdravotní péče $x metody $x organizace a řízení $x normy $7 D003695
- 650 _2
- $a diabetes mellitus $x epidemiologie $x mortalita $x terapie $7 D003920
- 650 _2
- $a studium lékařství $x metody $x organizace a řízení $7 D004501
- 650 _2
- $a endokrinologie $x metody $x organizace a řízení $x normy $7 D004704
- 650 _2
- $a Evropská unie $x organizace a řízení $x statistika a číselné údaje $7 D005062
- 650 _2
- $a zeměpis $7 D005843
- 650 _2
- $a zdravotnický personál $x normy $x statistika a číselné údaje $7 D006282
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a internacionalita $7 D038622
- 650 _2
- $a pediatrie $x metody $x organizace a řízení $x normy $7 D010372
- 650 _2
- $a kvalita zdravotní péče $7 D011787
- 650 _2
- $a průzkumy a dotazníky $7 D011795
- 650 _2
- $a referenční standardy $7 D012015
- 655 _2
- $a hodnotící studie $7 D023362
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 700 1_
- $a Sumník, Zdeněk $u -
- 700 1_
- $a de Beaufort, Carine $u -
- 700 1_
- $a Rurik, Imre $u -
- 700 1_
- $a Vazeou, Andriani $u -
- 700 1_
- $a Madácsy, László $u -
- 700 1_
- $a Papo, Natalie L $u -
- 700 1_
- $a Danne, Thomas $u -
- 700 1_
- $a , $u -
- 773 0_
- $w MED00181048 $t Pediatric diabetes $x 1399-5448 $g Roč. 13 Suppl 16(2012), s. 5-14
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22931219 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130404 $b ABA008
- 991 __
- $a 20130408112423 $b ABA008
- 999 __
- $a ok $b bmc $g 975578 $s 810661
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 13 Suppl 16 $d 5-14 $i 1399-5448 $m Pediatric diabetes $n Pediatr Diabetes $x MED00181048
- LZP __
- $a Pubmed-20130404